To evaluate the efficacy and safety of single combined (long- or short-acting beta₂ agonist plus an inhaled corticosteroid (ICS)) inhaler only used as needed in people with mild asthma.
This is a protocol.
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
You may also be interested in:
- Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease
- Can taking inhaled corticosteroids when needed for symptoms help people with mild asthma from becoming more unwell?
- Fixed-dose combinations for treating pulmonary tuberculosis
- What is the evidence for stopping long-acting beta2-agonists for adults with stable asthma using combination therapy?
- Overview of the safety of regular formoterol or salmeterol in adults with asthma